Can choline PET tackle the challenge of imaging prostate cancer?

Theranostics

Volumn 2, Issue 3, 2012, Pages 331-332

  Jadvar, Hossein ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cancer; Choline; PET; Prostate

Indexed keywords

ANDROGEN RECEPTOR; CARBON 11; CHOLINE; CHOLINE KINASE; FLUORODEOXYGLUCOSE F 18; GASTRIN RELEASING PEPTIDE RECEPTOR; PHOSPHATIDYLCHOLINE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROSTATE STEM CELL ANTIGEN; TRACER;

AMINO ACID METABOLISM; ANGIOGENESIS; BIOCHEMICAL FAILURE FREE SURVIVAL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER THERAPY; CASTRATION RESISTANT PROSTATE CANCER; CELL MEMBRANE; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DNA SYNTHESIS; DRUG TUMOR LEVEL; EDITORIAL; EUROPE; FATTY ACID METABOLISM; GENE PROBE; GLUCOSE METABOLISM; HUMAN; HYPOXIA; ISOTOPE LABELING; JAPAN; LIPOGENESIS; MALE; MOLECULAR IMAGING; MOLECULAR PATHOLOGY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PROSTATE CANCER; SALVAGE THERAPY; TUMOR CELL; UPREGULATION;

EID: 84864548171     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.4288     Document Type: Editorial

References (8)

1. Scher HI, Morris MJ, Basch E, et al. End points and outcomes in castration-resistant prostate cancer: from clinical trials to clini-cal practice. J Clin Oncol 2011; 29:3695-3704.
2. Hoeks CM, Barentsz JC, Hambrock T, et al. Prostate cancer: multiparametric MR imaging for detection, localization and staging. Radiology 2011; 261:46-66.
3. Lord M, Ratib O, Vallee JP. 18F-fluorocholine integrated PET/MRI for the initial staging of prostate cancer. Eur J Nucl Med Mol Imaging 2011; 38:2288.
4. Aplolo AB, Pandit-Taskar N, Morris MJ. Novel tracers and their development for the imaging of metastatic prostate cancer. J Nucl Med 2008; 49:2031-41.
5. Jadvar H. Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline. J Nucl Med 2011; 52:81-9.
6. Picchio M, Briganti M, Fanti S, et al. The role of choline positron emission tomography/computed tomog-raphy in the management of patients with prostate-specific an-tigen progression after radical treatment of prostate cancer. Eur Urol 2011; 59:51-60.
7. Schwarzenböck S, Souvatzoglou M, Krause BJ. Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer. Theranostics 2012; 2(3):318-330.
8. 11C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse. Theranostics 2012; 2(3):313-317.